152 related articles for article (PubMed ID: 14765130)
1. Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation.
Rosser CJ; Tanaka M; Pisters LL; Tanaka N; Levy LB; Hoover DC; Grossman HB; McDonnell TJ; Kuban DA; Meyn RE
Cancer Gene Ther; 2004 Apr; 11(4):273-9. PubMed ID: 14765130
[TBL] [Abstract][Full Text] [Related]
2. PTEN gene therapy induces growth inhibition and increases efficacy of chemotherapy in prostate cancer.
Tanaka M; Rosser CJ; Grossman HB
Cancer Detect Prev; 2005; 29(2):170-4. PubMed ID: 15829377
[TBL] [Abstract][Full Text] [Related]
3. In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin.
Tanaka M; Grossman HB
Gene Ther; 2003 Sep; 10(19):1636-42. PubMed ID: 12923562
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells.
Davies MA; Kim SJ; Parikh NU; Dong Z; Bucana CD; Gallick GE
Clin Cancer Res; 2002 Jun; 8(6):1904-14. PubMed ID: 12060635
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation.
Colletier PJ; Ashoori F; Cowen D; Meyn RE; Tofilon P; Meistrich ME; Pollack A
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1507-12. PubMed ID: 11121656
[TBL] [Abstract][Full Text] [Related]
6. PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression.
Huang H; Cheville JC; Pan Y; Roche PC; Schmidt LJ; Tindall DJ
J Biol Chem; 2001 Oct; 276(42):38830-6. PubMed ID: 11495901
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo.
Saito Y; Swanson X; Mhashilkar AM; Oida Y; Schrock R; Branch CD; Chada S; Zumstein L; Ramesh R
Gene Ther; 2003 Nov; 10(23):1961-9. PubMed ID: 14528320
[TBL] [Abstract][Full Text] [Related]
8. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway.
Yuan XJ; Whang YE
Oncogene; 2002 Jan; 21(2):319-27. PubMed ID: 11803475
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN.
Davies MA; Koul D; Dhesi H; Berman R; McDonnell TJ; McConkey D; Yung WK; Steck PA
Cancer Res; 1999 Jun; 59(11):2551-6. PubMed ID: 10363971
[TBL] [Abstract][Full Text] [Related]
10. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.
Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK
Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.
Davies MA; Lu Y; Sano T; Fang X; Tang P; LaPushin R; Koul D; Bookstein R; Stokoe D; Yung WK; Mills GB; Steck PA
Cancer Res; 1998 Dec; 58(23):5285-90. PubMed ID: 9850049
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
[TBL] [Abstract][Full Text] [Related]
13. [PTEN and p27Kip1 have a cooperative role on inhibition proliferation, modulation of cell cycle and inducing apoptosis in prostate cancer PC-3 cell].
Qiu Z; Sun YH; Xu CL; Wang YT; Gu ZQ; Liu Y
Zhonghua Wai Ke Za Zhi; 2004 May; 42(10):600-3. PubMed ID: 15265403
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of PTEN/MMAC/TEP1 expression in human prostate cancer cell line DU145 by growth stimuli.
Bastola DR; Pahwa GS; Lin MF; Cheng PW
Mol Cell Biochem; 2002 Jul; 236(1-2):75-81. PubMed ID: 12190124
[TBL] [Abstract][Full Text] [Related]
15. Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation.
Cao W; Yacoub S; Shiverick KT; Namiki K; Sakai Y; Porvasnik S; Urbanek C; Rosser CJ
Prostate; 2008 Aug; 68(11):1223-31. PubMed ID: 18465755
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of BCL-2 induces downregulation of carbonic anhydrase IX, vascular endothelial growth factor, and pAkt and induces radiation sensitization.
Anai S; Shiverick K; Medrano T; Nakamura K; Goodison S; Brown BD; Rosser CJ
Urology; 2007 Oct; 70(4):832-7. PubMed ID: 17991582
[TBL] [Abstract][Full Text] [Related]
17. Combination of PTEN gene therapy and radiation inhibits the growth of human prostate cancer xenografts.
Anai S; Goodison S; Shiverick K; Iczkowski K; Tanaka M; Rosser CJ
Hum Gene Ther; 2006 Oct; 17(10):975-84. PubMed ID: 16984224
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells.
Spurgers KB; Coombes KR; Meyn RE; Gold DL; Logothetis CJ; Johnson TJ; McDonnell TJ
Oncogene; 2004 Mar; 23(9):1712-23. PubMed ID: 14647426
[TBL] [Abstract][Full Text] [Related]
19. Antisense Bcl-2 sensitizes prostate cancer cells to radiation.
Mu Z; Hachem P; Pollack A
Prostate; 2005 Dec; 65(4):331-40. PubMed ID: 16015611
[TBL] [Abstract][Full Text] [Related]
20. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
